Farnier, M, Jones, P, Severance, R, Averna, M, Steinhagen-Thiessen, E, Colhoun, H M, Du, Y, Hanotin, C & Donahue, S 2016, ' Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients : The ODYSSEY OPTIONS II randomized trial ', Atherosclerosis, vol. 244, pp. 138-46 . https://doi.org/10.1016/j.atherosclerosis.2015.11.010